+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Continuous Blood Glucose Monitoring Systems Market Research Report by Product, Component, Testing Site, Patient Care Setting, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 156 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5122542
UP TO OFF until Dec 31st 2022
The United States Continuous Blood Glucose Monitoring Systems Market size was estimated at USD 786.84 million in 2021, USD 892.37 million in 2022, and is projected to grow at a CAGR 9.87% to reach USD 1,384.18 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Continuous Blood Glucose Monitoring Systems to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Continuous Glucose Monitoring Systems and Self-Monitoring Blood Glucose Systems. The Continuous Glucose Monitoring Systems is further studied across Receivers, Sensors, and Transmitters. The Self-Monitoring Blood Glucose Systems is further studied across Blood Glucose meters, Lancets & Lancing Devices, and Testing strips.
  • Based on Component, the market was studied across CGM Monitor, CGM Transmitter, and Glucose Sensor.
  • Based on Testing Site, the market was studied across Alternate Site Testing and Fingertip testing.
  • Based on Patient Care Setting, the market was studied across Hospital & Clinics and Self/Home Care.
  • Based on Application, the market was studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Continuous Blood Glucose Monitoring Systems market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Continuous Blood Glucose Monitoring Systems Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Continuous Blood Glucose Monitoring Systems Market, including A Menarini Diagnostics Ltd., Abbott Laboratories, B. Braun Melsungen AG, Bayer AG, Dexcom, Inc., Echo Therapeutics, Inc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlySens Incorporated, Integrity Applications Inc, Johnson & Johnson Services, Inc., LifeScan IP Holdings, LLC, Medtronic PLC, Novo Nordisk A/S, OrSense Ltd, PHC Holdings Corporation, Senseonics Holdings, Inc., and Tandem Diabetes Care, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Continuous Blood Glucose Monitoring Systems Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Continuous Blood Glucose Monitoring Systems Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Continuous Blood Glucose Monitoring Systems Market?
4. What is the competitive strategic window for opportunities in the United States Continuous Blood Glucose Monitoring Systems Market?
5. What are the technology trends and regulatory frameworks in the United States Continuous Blood Glucose Monitoring Systems Market?
6. What is the market share of the leading vendors in the United States Continuous Blood Glucose Monitoring Systems Market?
7. What modes and strategic moves are considered suitable for entering the United States Continuous Blood Glucose Monitoring Systems Market?
Frequently Asked Questions about the U.S. Continuous Blood Glucose Monitoring Systems Market

What is the estimated value of the U.S. Continuous Blood Glucose Monitoring Systems Market?

The U.S. Continuous Blood Glucose Monitoring Systems Market was estimated to be valued at $786.84 Million in 2021.

What is the growth rate of the U.S. Continuous Blood Glucose Monitoring Systems Market?

The growth rate of the U.S. Continuous Blood Glucose Monitoring Systems Market is 9.8%, with an estimated value of $1384.18 Million by 2027.

What is the forecasted size of the U.S. Continuous Blood Glucose Monitoring Systems Market?

The U.S. Continuous Blood Glucose Monitoring Systems Market is estimated to be worth $1384.18 Million by 2027.

Who are the key companies in the U.S. Continuous Blood Glucose Monitoring Systems Market?

Key companies in the U.S. Continuous Blood Glucose Monitoring Systems Market include A Menarini Diagnostics Ltd., Abbott Laboratories, B. Braun Melsungen AG, Bayer AG, Dexcom, Inc., Echo Therapeutics, Inc, Eli Lilly and Company, F. Hoffmann and GlySens Incorporated.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Continuous Blood Glucose Monitoring Systems Market, by Product
6.1. Introduction
6.2. Continuous Glucose Monitoring Systems
6.2.1. Receivers
6.2.2. Sensors
6.2.3. Transmitters
6.3. Self-Monitoring Blood Glucose Systems
6.3.1. Blood Glucose meters
6.3.2. Lancets & Lancing Devices
6.3.3. Testing strips
7. Continuous Blood Glucose Monitoring Systems Market, by Component
7.1. Introduction
7.2. CGM Monitor
7.3. CGM Transmitter
7.4. Glucose Sensor
8. Continuous Blood Glucose Monitoring Systems Market, by Testing Site
8.1. Introduction
8.2. Alternate Site Testing
8.3. Fingertip testing
9. Continuous Blood Glucose Monitoring Systems Market, by Patient Care Setting
9.1. Introduction
9.2. Hospital & Clinics
9.3. Self/Home Care
10. Continuous Blood Glucose Monitoring Systems Market, by Application
10.1. Introduction
10.2. Gestational Diabetes
10.3. Type 1 Diabetes
10.4. Type 2 Diabetes
11. California Continuous Blood Glucose Monitoring Systems Market12. Florida Continuous Blood Glucose Monitoring Systems Market13. Illinois Continuous Blood Glucose Monitoring Systems Market14. New York Continuous Blood Glucose Monitoring Systems Market15. Ohio Continuous Blood Glucose Monitoring Systems Market16. Pennsylvania Continuous Blood Glucose Monitoring Systems Market17. Texas Continuous Blood Glucose Monitoring Systems Market
18. Competitive Landscape
18.1. FPNV Positioning Matrix
18.1.1. Quadrants
18.1.2. Business Strategy
18.1.3. Product Satisfaction
18.2. Market Ranking Analysis
18.3. Market Share Analysis, By Key Player
18.4. Competitive Scenario
18.4.1. Merger & Acquisition
18.4.2. Agreement, Collaboration, & Partnership
18.4.3. New Product Launch & Enhancement
18.4.4. Investment & Funding
18.4.5. Award, Recognition, & Expansion
19. Company Usability Profiles
19.1. A Menarini Diagnostics Ltd.
19.2. Abbott Laboratories
19.3. B. Braun Melsungen AG
19.4. Bayer AG
19.5. Dexcom, Inc.
19.6. Echo Therapeutics, Inc
19.7. Eli Lilly and Company
19.8. F. Hoffmann-La Roche Ltd
19.9. GlySens Incorporated
19.10. Integrity Applications Inc
19.11. Johnson & Johnson Services, Inc.
19.12. LifeScan IP Holdings, LLC
19.13. Medtronic PLC
19.14. Novo Nordisk A/S
19.15. OrSense Ltd
19.16. PHC Holdings Corporation
19.17. Senseonics Holdings, Inc.
19.18. Tandem Diabetes Care, Inc.
20. Appendix
20.1. Discussion Guide
20.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET DYNAMICS
FIGURE 8. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 20. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2019-2027 (USD MILLION)
FIGURE 22. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY BLOOD GLUCOSE METERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LANCETS & LANCING DEVICES, 2019-2027 (USD MILLION)
FIGURE 24. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LANCETS & LANCING DEVICES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING STRIPS, 2019-2027 (USD MILLION)
FIGURE 26. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING STRIPS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2021 VS 2027 (%)
FIGURE 28. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2021 VS 2027 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2027
FIGURE 30. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM MONITOR, 2019-2027 (USD MILLION)
FIGURE 31. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM MONITOR, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 32. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM TRANSMITTER, 2019-2027 (USD MILLION)
FIGURE 33. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM TRANSMITTER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GLUCOSE SENSOR, 2019-2027 (USD MILLION)
FIGURE 35. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GLUCOSE SENSOR, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2021 VS 2027 (%)
FIGURE 37. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2021 VS 2027 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2027
FIGURE 39. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ALTERNATE SITE TESTING, 2019-2027 (USD MILLION)
FIGURE 40. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ALTERNATE SITE TESTING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 41. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY FINGERTIP TESTING, 2019-2027 (USD MILLION)
FIGURE 42. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY FINGERTIP TESTING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 43. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2021 VS 2027 (%)
FIGURE 44. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2021 VS 2027 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2027
FIGURE 46. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITAL & CLINICS, 2019-2027 (USD MILLION)
FIGURE 47. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITAL & CLINICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 48. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF/HOME CARE, 2019-2027 (USD MILLION)
FIGURE 49. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF/HOME CARE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 50. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 51. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2027
FIGURE 53. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, 2019-2027 (USD MILLION)
FIGURE 54. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 55. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, 2019-2027 (USD MILLION)
FIGURE 56. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 57. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, 2019-2027 (USD MILLION)
FIGURE 58. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 59. CALIFORNIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. FLORIDA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. ILLINOIS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. NEW YORK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. OHIO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. PENNSYLVANIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. TEXAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 67. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY BLOOD GLUCOSE METERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LANCETS & LANCING DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING STRIPS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM MONITOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM TRANSMITTER, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GLUCOSE SENSOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ALTERNATE SITE TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY FINGERTIP TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITAL & CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF/HOME CARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 25. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. CALIFORNIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 29. CALIFORNIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 30. CALIFORNIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 31. CALIFORNIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2019-2027 (USD MILLION)
TABLE 32. CALIFORNIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2019-2027 (USD MILLION)
TABLE 33. CALIFORNIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 34. FLORIDA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 35. FLORIDA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 36. FLORIDA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 37. FLORIDA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2019-2027 (USD MILLION)
TABLE 38. FLORIDA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2019-2027 (USD MILLION)
TABLE 39. FLORIDA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 40. ILLINOIS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. ILLINOIS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 42. ILLINOIS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 43. ILLINOIS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2019-2027 (USD MILLION)
TABLE 44. ILLINOIS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2019-2027 (USD MILLION)
TABLE 45. ILLINOIS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 46. NEW YORK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 47. NEW YORK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 48. NEW YORK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 49. NEW YORK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2019-2027 (USD MILLION)
TABLE 50. NEW YORK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2019-2027 (USD MILLION)
TABLE 51. NEW YORK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 52. OHIO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. OHIO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 54. OHIO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 55. OHIO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2019-2027 (USD MILLION)
TABLE 56. OHIO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2019-2027 (USD MILLION)
TABLE 57. OHIO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 58. PENNSYLVANIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. PENNSYLVANIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 60. PENNSYLVANIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 61. PENNSYLVANIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2019-2027 (USD MILLION)
TABLE 62. PENNSYLVANIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2019-2027 (USD MILLION)
TABLE 63. PENNSYLVANIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 64. TEXAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. TEXAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 66. TEXAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2019-2027 (USD MILLION)
TABLE 67. TEXAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2019-2027 (USD MILLION)
TABLE 68. TEXAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2019-2027 (USD MILLION)
TABLE 69. TEXAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 70. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 71. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 72. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 73. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET RANKING
TABLE 74. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 75. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET MERGER & ACQUISITION
TABLE 76. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 77. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 78. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET INVESTMENT & FUNDING
TABLE 79. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 80. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET: LICENSE & PRICING

Companies Mentioned

  • A Menarini Diagnostics Ltd.
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Bayer AG
  • Dexcom, Inc.
  • Echo Therapeutics, Inc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlySens Incorporated
  • Integrity Applications Inc
  • Johnson & Johnson Services, Inc.
  • LifeScan IP Holdings, LLC
  • Medtronic PLC
  • Novo Nordisk A/S
  • OrSense Ltd
  • PHC Holdings Corporation
  • Senseonics Holdings, Inc.
  • Tandem Diabetes Care, Inc.

Methodology

Loading
LOADING...